Forces and structural limitations of binding of thyrotrophin-releasing factor to the thyrotrophin-releasing receptor: the pyroglutamic acid moiety
- PMID: 196172
Forces and structural limitations of binding of thyrotrophin-releasing factor to the thyrotrophin-releasing receptor: the pyroglutamic acid moiety
Similar articles
-
Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal.Mol Cell Biochem. 1981 Aug 11;38 Spec No(Pt 1):181-90. doi: 10.1007/BF00235695. Mol Cell Biochem. 1981. PMID: 6117006 Review.
-
Conformationally restricted TRH analogs: a probe for the pyroglutamate region.J Med Chem. 1996 Apr 12;39(8):1571-4. doi: 10.1021/jm960053k. J Med Chem. 1996. PMID: 8648595 No abstract available.
-
Synthesis of a series of residue 1 (pyroglutamic acid) analogs of thyrotrophin releasing hormone.Int J Pept Protein Res. 1979;14(3):216-26. doi: 10.1111/j.1399-3011.1979.tb01928.x. Int J Pept Protein Res. 1979. PMID: 118133
-
Investigations on the binding properties of the nootropic agent pyroglutamic acid.Drugs Exp Clin Res. 1990;16(2):85-99. Drugs Exp Clin Res. 1990. PMID: 1976055
-
The metabolic formation and utilization of 5-oxo-L-proline (L-pyroglutamate, L-pyrrolidone carboxylate).Adv Enzymol Relat Areas Mol Biol. 1975;43:519-56. doi: 10.1002/9780470122884.ch7. Adv Enzymol Relat Areas Mol Biol. 1975. PMID: 1106127 Review. No abstract available.
Cited by
-
N-terminal pyroglutamate formation in CX3CL1 is essential for its full biologic activity.Biosci Rep. 2017 Aug 23;37(4):BSR20170712. doi: 10.1042/BSR20170712. Print 2017 Aug 31. Biosci Rep. 2017. PMID: 28739588 Free PMC article.
-
Linked production of pyroglutamate-modified proteins via self-cleavage of fusion tags with TEV protease and autonomous N-terminal cyclization with glutaminyl cyclase in vivo.PLoS One. 2014 Apr 14;9(4):e94812. doi: 10.1371/journal.pone.0094812. eCollection 2014. PLoS One. 2014. PMID: 24733552 Free PMC article.
-
Structural and functional analyses of a glutaminyl cyclase from Ixodes scapularis reveal metal-independent catalysis and inhibitor binding.Acta Crystallogr D Biol Crystallogr. 2014 Mar;70(Pt 3):789-801. doi: 10.1107/S1399004713033488. Epub 2014 Feb 22. Acta Crystallogr D Biol Crystallogr. 2014. PMID: 24598748 Free PMC article.
-
Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal.Mol Cell Biochem. 1981 Aug 11;38 Spec No(Pt 1):181-90. doi: 10.1007/BF00235695. Mol Cell Biochem. 1981. PMID: 6117006 Review.
-
Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding.J Biol Chem. 2011 Apr 8;286(14):12439-49. doi: 10.1074/jbc.M110.208595. Epub 2011 Feb 1. J Biol Chem. 2011. PMID: 21288892 Free PMC article.